Paul Smith
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Epidemiology top 5%
- Autophagy in Disease and Therapy
Papers in ⓘ
- Co-authors
- Tim Crook (4 shared papers)Diane Crighton (1 shared paper)Milena Gasco (1 shared paper)Ornella Garrone (1 shared paper)Simon Wilkinson (1 shared paper)Paul R. Harrison (1 shared paper)Kevin M. Ryan (1 shared paper)Jim O’Prey (1 shared paper)
- Journals
- Cancer Research (4 papers)Biochemical Journal (2 papers)Oncogene (2 papers)Cell Metabolism (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Paul Smith
28 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 351
- Epidemiology 758
- Physiology 98
- Geriatrics and Gerontology 75
- Oncology 458
Countries citing papers authored by Paul Smith
This map shows the geographic impact of Paul Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Smith more than expected).
Fields of papers citing papers by Paul Smith
This network shows the impact of papers produced by Paul Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Smith. The network helps show where Paul Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis Hit paper breakdown → | 2006 | 1093 |
| 2 | 1998 | 137 | |
| 3 | Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. | 2003 | 89 |
| 4 | 1999 | 84 | |
| 5 | 1987 | 61 | |
| 6 | 2021 | 50 | |
| 7 | 2009 | 46 | |
| 8 | 2010 | 44 | |
| 9 | 2005 | 36 | |
| 10 | 2009 | 35 | |
| 11 | 1998 | 31 | |
| 12 | 2018 | 30 | |
| 13 | 1996 | 22 | |
| 14 | 2006 | 20 | |
| 15 | 2009 | 16 | |
| 16 | 2024 | 15 | |
| 17 | 2015 | 15 | |
| 18 | 2005 | 14 | |
| 19 | 2012 | 11 | |
| 20 | 2019 | 9 |
About Paul Smith
Paul Smith is a scholar working on Health Informatics, Developmental Neuroscience, Cancer Research, Oncology and Museology, having authored 31 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers), CRISPR and Genetic Engineering (2 papers), Cancer Genomics and Diagnostics (2 papers), Meningioma and schwannoma management (2 papers), DNA Repair Mechanisms (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Cancer Research (351 citations), Epidemiology (758 citations), Physiology (98 citations), Geriatrics and Gerontology (75 citations) and Oncology (458 citations). Paul Smith has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Tim Crook, Diane Crighton, Milena Gasco, Ornella Garrone, Simon Wilkinson, Paul R. Harrison, Kevin M. Ryan, Jim O’Prey, Nelofer Syed and M. Rufus Crompton. Their work appears in journals such as Cancer Research, Biochemical Journal, Oncogene, Cell Metabolism and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.